| Literature DB >> 32368635 |
C García-Navarro1,2, S Jimenez de Ory3,4, C Velo Higueras1,2, B Zamora1, L Prieto5, J T Ramos6,7,8, M L Navarro3,4,7,9, L Escosa-García10,11, R Jurado-Barba2,12, Dolores Falcón13, David Moreno14,15, M I González-Tomé1.
Abstract
Delayed neurodevelopment is a common outcome in perinatally HIV-infected children. Our aim was to assess the intellectual profile of our cohort, considering both the infection and socio-environmental related variables. A cross-sectional cohort study was undertaken at seven major hospitals in Spain belonging to the CoRISpeS cohort (n = 97). Patients were followed up according to a standard protocol. Intellectual measures, psychosocial profile and HIV infection-related data have been analysed. The average patient age was 15 years. The median CD4 cell percentage was 35% (1,59). Viral load was undetectable in 80% of the patients and 27% were on AIDS category; 38% of whom had encephalopathy. The average composite score of both crystallized intelligence (CI) and intelligence quotient (IQ) for the cohort was lower than that of the general population (p < 0.001). Results revealed a significant difference of 38% between crystallized and fluid intelligence. There was a clear association between IQ and age of diagnosis (p = 0.022); CI and CDC classification (p = 0.035), CD4 count (p = 0.011) and CD4 nadir (p = 0.001). Higher parental education was associated with better performance across all intelligence scales (p < 0.002). A regression model showed that CI was influenced by the academic level of caregivers (p = 0.002), age at start of cART (p = 0.050) and primary language (p = 0.058). Findings revealed significant differences in verbal and non-verbal intellectual scales resulting in a misleading IQ Composite score. Crystallized intelligence demonstrated the highest level of impairment despite adequate treatment and good immunovirological status, while fluid intelligence results were average. Caregiver level of education was the strongest factor across all intelligence measures.Entities:
Keywords: Cognition; Cognitive psychology; HIV; IQ; Intelligence; Learning and memory; Psychology; Vertical transmission; Virology
Year: 2020 PMID: 32368635 PMCID: PMC7184518 DOI: 10.1016/j.heliyon.2020.e03600
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Characteristics of 97 HIV-infected patients' sample.
| Mean age (years, SD) | 15 (4.51) | |
| 5–16 years (%, n) | 60% (58) | |
| 17–23 years (%, n) | 40% (39) | |
| Sociodemographic characteristics (%, n) | ||
| 66% (64) | ||
| Caucasian | 64% (62) | |
| Sub Saharan Africa | 11% (11) | |
| South America | 8% (8) | |
| Other | 17% (16) | |
| Family structure | ||
| Biologic parent/s | 49% (47) | |
| Grandparents or extended family | 16% (15) | |
| Foster care or adoption | 29% (28) | |
| Other | 7% (7) | |
| Parental education (most educated caregiver) | ||
| No education/Read and write | 17% (16) | |
| Elementary/Secondary school | 31% (30) | |
| High school or higher degrees | 47% (46) | |
| Unknown | 5% (5) | |
| Attending at school | 85% (82) | |
| Number of repeated grades | ||
| 0 | 27% (26) | |
| 1 | 28% (27) | |
| ≥2 | 35% (34) | |
| No data | 10% (10) | |
| Reported academic performance | ||
| Good | 29% (28) | |
| Poor | 41% (40) | |
| With difficulties | 20% (19) | |
| No data | 10% (10) | |
| Immunological and virological characteristics at study entry | ||
| AIDS (%, n) | 27% (26) | |
| HIV-Encephalopathy (%, n) | 10% (10) | |
| Hepatitis C virus (%, n) | 6% (6) | |
| Median CD4 cells/mm3 (IQR) | 770 (570, 1004) | |
| Median CD4 % (IQR) | 35 (30, 40) | |
| Median CD4/CD8 (IQR) | 1.00 (0.7, 1.40) | |
| Viral load <50 cop/ml (%, n) | 80% (78) | |
| Median Nadir CD4 cells/mm3 (IQR) | 360 (185, 463) | |
| Median Nadir CD4 % (IQR) | 15% (10, 22) | |
| Median age at diagnosis (IQR) | 0.46 (0, 12.24) | |
| Antiretroviral treatment (years, IQR) | ||
| Median age at the start of ART (IQR) | 1.34 (0.01, 14) | |
| Median age at the start of cART (IQR) | 2.62 (0.01, 15) | |
| Time of treatment with ART (IQR) | 12.45 (0.98, 21) | |
| Time of treatment with cART (IQR) | 11.10 (0.51, 17) | |
| Median number of cART regimens (IQR) | 4 (0, 12) | |
| Current treatment situation (%, n) | ||
| Patients without ART | 6% (6) | |
| Patients with cART | 89% (86) | |
| Good adherence to treatment | 86% (78) | |
Abbreviations: SD: Standard Deviation, AIDS: Acquired Immune Deficiency Syndrome, HIV: Human Immunodeficiency Virus, CD4: CD4 T lymphocytes, IQR: Interquartile range, ART: Antiretroviral therapy, cART: Combination Antiretroviral Therapy.
Figure 1Intellectual performance of perinatally HIV-infected patients. Whole sample. Mean value (SD), CI: 91 (15); FI: 100 (10); IQ: 93 (12); Normative data: 100 (15). The mean of both CI and IQ Composite score was lower than in the general population (one-sample t-test for means: CI t = -5.979, p < 0.001; IQ t = -6.025, p < 0.001).
Intellectual performance of perinatally HIV-infected subjects. Differences between patients who obtained homogeneous measures in both verbal and non-verbal scale and those who did not.
| Parameter | Cohort (n = 97) | Homogeneous measures group (n = 60) | Discordant measures group (n = 37) | Homogeneous vs discordant measures group | |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean difference | p-value | |
| Crystallized intelligence | 91 (15) | 95 (12) | 84 (17) | 10.872 | |
| Fluid intelligence | 100 (10) | 99 (10) | 101 (10) | -2.231 | 0.290 |
| IQ Composite score | 93 (12) | 94 (12) | 90 (13) | 4.816 | 0.058 |
Normative data, Mean value (SD): 100 (15). P-values less than 0.05 were considered statistically significant.
Independent Samples T Test, two-sided.
Associations between intelligence measures and HIV clinical data.
| Crystallized Intelligence | Fluid Intelligence | IQ Composite Score | |
|---|---|---|---|
| 0.712 | 0.794 | ||
| 0.149 | 0.110 | ||
| 0.529 | 0.640 | 0.978 | |
| 0.283 | 0.512 | ||
| 0.059 | 0.313 | 0.270 | |
| 0.077 | 0.130 | 0.181 | |
| 0.067 | 0.835 | 0.689 | |
| 0.115 | 0.889 | 0.022 | |
| 0.089 | 0.844 | 0.286 | |
| 0.901 | 0.827 | 0.157 |
Abbreviations: CDC: U.S. Centers for Disease Control and Prevention classification system for HIV infection. AIDS: Acquired Immune Deficiency Syndrome. cART: Combination Antiretroviral Therapy. P-values less than 0.05 were considered statistically significant.
Kruskal-Wallis Test p-value.
Contingency tables, chi-square test p-value.
Figure 2Intellectual performance of PHIV patients depending on their caregiver's level of schooling. Performance across all intelligence measures was better in those patients whose caregivers had achieved higher grades (p < 0.002).
Relationship between intelligence measures and education-related variables.
| Crystallized Intelligence | Fluid Intelligence | Intelligence Quotient | ||||
|---|---|---|---|---|---|---|
| Spearman correlation | p-value | Spearman correlation | p-value | Spearman correlation | p-value | |
| Academic performance | r = 0.354 | r = 0.289 | r = 0.361 | |||
| Repeated grades | r = -0.304 | r = -0.121 | 0.260 | r = -0.263 | ||
| Caregiver level of education | r = 0.458 | r = 0.313 | r = 0.459 | |||
P-values less than 0.05 were considered statistically significant.
Associations with crystallized intelligence in the multivariate linear regression model. Whole sample.
| Parameter | B | p-value | Confidence Interval (95%) | |
|---|---|---|---|---|
| Lower limit | Upper limit | |||
| Primary language | -9.446 | -19.207 | 0.315 | |
| Adherence | -0.495 | 0.883 | -7.188 | 6.198 |
| -18.171 | -25.588 | -10.754 | ||
| -9.634 | -15.759 | -3.509 | ||
| Age at start of cART | -0.741 | -1.485 | 0.002 | |
| Nadir CD4 (%) | 0.195 | 0.201 | -0.106 | 0.497 |
Abbreviations: CG: Caregiver. cART: Combination Antiretroviral Therapy. CD4: CD4 T lymphocytes. P-values less than 0.05 were considered statistically significant.
Elementary school vs Secondary or higher education (Caregiver education).
Elementary/Compulsory education vs Secondary or higher (Caregiver education).